Nextech Invest, Ltd. Silence Therapeutics PLC Transaction History
Nextech Invest, Ltd.
- $430 Billion
- Q1 2025
A detailed history of Nextech Invest, Ltd. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Nextech Invest, Ltd. holds 952,400 shares of SLN stock, worth $4 Million. This represents 0.62% of its overall portfolio holdings.
Number of Shares
952,400Holding current value
$4 Million% of portfolio
0.62%Shares
1 transactions
Others Institutions Holding SLN
# of Institutions
61Shares Held
22.7MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$12.7 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.79MShares$11.7 Million0.45% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$9.3 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$8.4 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$7.77 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $151M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...